Puma Biotechnology, Inc.
PBYINASDAQHealthcare● Active
$6.85
$-0.18(-2.56%)
Market Cap$348661274
P/E Ratio—
52W High$7.9
52W Low$3.03
Puma Biotechnology, Inc.（PBYI）· 资产负债表
年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q（经 FMP 聚合）· 可在下方切换周期与 M/B/T 单位。
FMP · PBYI · 截至 2026-06-10
财务报表
Total Assets · Total Liabilities · Equity
| Breakdown | 2025-12 | 2024-12 | 2023-12 | 2022-12 | 2021-12 |
|---|---|---|---|---|---|
| Assets | |||||
| Cash & ST Investments | $0.10B | $0.10B | $0.10B | $0.08B | $0.08B |
| Net Receivables | $0.05B | $0.03B | $0.05B | $0.04B | $0.03B |
| Inventory | $0.01B | $0.01B | $0.01B | $0.00B | $0.01B |
| Total Current Assets | $0.16B | $0.15B | $0.16B | $0.13B | $0.14B |
| PP&E Net | $0.01B | $0.01B | $0.01B | $0.01B | $0.02B |
| Goodwill | $0.00B | $0.00B | $0.00B | $0.00B | $0.00B |
| Intangible Assets | $0.04B | $0.05B | $0.06B | $0.07B | $0.07B |
| Total Assets | $0.22B | $0.21B | $0.23B | $0.22B | $0.23B |
| Liabilities | |||||
| Short-Term Debt | $0.02B | $0.05B | $0.03B | $0.00B | $0.00B |
| Accounts Payable | $0.01B | $0.01B | $0.01B | $0.01B | $0.01B |
| Total Current Liabilities | $0.08B | $0.10B | $0.10B | $0.08B | $0.11B |
| Long-Term Debt | $0.00B | $0.02B | $0.07B | $0.10B | $0.10B |
| Total Liabilities | $0.09B | $0.12B | $0.18B | $0.20B | $0.23B |
| Stockholders Equity | |||||
| Retained Earnings | ($1.28B) | ($1.31B) | ($1.35B) | ($1.37B) | ($1.37B) |
| Total Stockholders Equity | $0.13B | $0.09B | $0.05B | $0.02B | ($0.00B) |
| Total Liab & Equity(computed) | $0.22B | $0.21B | $0.23B | $0.22B | $0.23B |
| Debt Summary | |||||
| Total Debt | $0.03B | $0.07B | $0.11B | $0.11B | $0.12B |
| Net Debt | ($0.00B) | $0.00B | $0.03B | $0.04B | $0.05B |
数据来源：Financial Modeling Prep · 最后更新：2026-06-10 · USD · B
深入了解Puma Biotechnology, Inc.
关于Puma Biotechnology, Inc.（PBYI）资产负债表
Puma Biotechnology, Inc.总资产$0.22B，现金及短期投资$0.10B，总负债$0.09B，总债务$0.03B，股东权益$0.13B。
常见问题
PBYI · 4 问Puma Biotechnology, Inc.总债务$0.03B，净债务($0.00B)。
PBYI total debtnet debtdebt to equity
· Source: FMP /stable/balance-sheet-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-10